Presentation Information
[Pj-087-6]Analysis of the characteristics of patients who receive anti-amyloid antibody drug therapy
Tadashi Tsukamoto1,2, Kazumi Nozaki2, Asumi Tomizawa2, Reikko Saika1,2, Atsuko Katsumoto1,2, Takuma Inagawa2,3, Harumasa Takano2,3,4, Takashi Osada2,5, Yoshie Omachi2,3, Yuji Takahashi1,2 (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Research Center for Dementia, National Center of Neurology and Psychiatry, Japan, 3.Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 4.Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, Japan, 5.Department of Internal Medeline, National Center of Neurology and Psychiatry, Japan)